All In Biotech

Drug Trial Radar · NCT04270747

A Study to Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Suffering With Neovascular Age-related Macular Degeneration [Neovascular (Wet) AMD]

A Randomized, Double-masked, Phase 3 Study of ABP 938 Efficacy and Safety Compared to Aflibercept (Eylea®) in Subjects With Neovascular Age-related Macular Degeneration

Last checked: Nov 19, 2026Latest source record: Sep 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 576 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

576

Actual

Start

Jun 22, 2020

Primary completion

Jul 18, 2022

Study completion Jan 30, 2023

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
Collaborators
Parexel
First posted
Feb 17, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the efficacy and safety of ABP 938 versus Aflibercept (Eylea®) in the treatment of neovascular age-related macular degeneration. Subjects will be randomized in a masked 1:1 ratio to receive 2 mg (0.05 mL) of either ABP 938 (Treatment Group A) or aflibercept (Treatment Group B) administered by intravitreal (IVT) injection.

Conditions

  • Neovascular (Wet) Age-related Macular Degeneration (AMD)

Interventions

  • ABP 938Drug

    Subject will receive ABP 938 2 mg (0.05 mL) IVT injection every 4 weeks for the first 3 doses, followed by once every 8 weeks

  • AfliberceptDrug

    Subject will receive aflibercept 2 mg (0.05 mL) IVT injection every 4 weeks for the first 3 doses, followed by once every 8 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Change From Baseline in BCVA at Week 8Time frame: Baseline and Week 8

Locations

118 sites in 18 countries. Site status is shown where the registry gives one.

  • Associated Retina Consultants, Ltd. - Research

    Phoenix, Arizona

  • Retina Consultants of Orange County

    Fullerton, California

  • UCSD Shiley Eye Institute, Jacobs Retina Center

    La Jolla, California

  • Jules Stein Eye Institute, UCLA

    Los Angeles, California

  • Southern California Desert Retina Consultants

    Palm Desert, California

  • Retina Consultants San Diego

    Poway, California

  • Retina Consultants of Southern California

    Redlands, California

  • Retinal Consultants Medical Group, Inc.

    Sacramento, California

  • Orange County Retina Medical Group

    Santa Ana, California

  • Miramar Eye Specialists

    Ventura, California

  • Colorado Retina Associates

    Lakewood, Colorado

  • Retina Group of New England

    Waterford, Connecticut

  • Florida Retina Consultants

    Lakeland, Florida

  • Medeye Associates

    Miami, Florida

  • Center for Retina and Macular Disease

    Winter Haven, Florida

  • Southeast Retina Center

    Augusta, Georgia

  • Georgia Retina, P.C.

    Marietta, Georgia

  • Retina Associates IL

    Elmhurst, Illinois

  • Sabates Eye Center

    Leawood, Kansas

  • Retina Associates New Orleans

    Metairie, Louisiana

  • The Retina Care Center

    Baltimore, Maryland

  • Specialty Eye Institute

    Jackson, Michigan

  • Retina Center

    Saint Louis Park, Minnesota

  • Retina Vitreous Surgeons of Central NY, PC

    Liverpool, New York

  • Macula Care

    New York, New York

  • Ophthalmic Consultants of the Capital Region - Ophthalmology

    Troy, New York

  • Charlotte Eye Ear Nose & Throat Associates, P.A.

    Charlotte, North Carolina

  • Sterling Research Group

    Cincinnati, Ohio

  • Eye Care Specialists

    Kingston, Pennsylvania

  • Charleston Neuroscience Institute

    Ladson, South Carolina

  • Black Hills Regional Eye Institute - Ophthalmology

    Rapid City, South Dakota

  • Retina Research Institute of Texas

    Abilene, Texas

  • Retina Consultants of Texas Research Centers

    Bellaire, Texas

  • Texas Retina Associates

    Dallas, Texas

  • Texas Retina Associates

    Fort Worth, Texas

  • Texas Retina Associates

    Fort Worth, Texas

  • Ophthalmology Associates

    Fort Worth, Texas

  • Premiere Retina Specialists

    Midland, Texas

  • Retina Associates of South Texas, P.A.

    San Antonio, Texas

  • Retina Consultants of Houston

    The Woodlands, Texas

Showing 40 of 118 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.